share_log

泰格醫藥:(1)關於終止實施2022年A股限制性股票激勵計劃並作廢限制性股票;(2)建議註銷回購股份兼變更本公司註冊資本;(3)以集中競價方式回購A股股份方案;及(4)臨時股東大會通告及H股類別股東會議通告

TIGERMED: (1) TERMINATION OF IMPLEMENTATION OF 2022 RESTRICTED A SHARE INCENTIVE SCHEME AND LAPSE OF RESTRICTED SHARES; (2) PROPOSED CANCELLATION OF REPURCHASED SHARES AND CHANGE OF THE REGISTERED CAPITAL OF THE COMPANY; (3) REPURCHASE OF A SHARES THROUGH CENTRALIZE

Hong Kong Stock Exchange ·  Apr 9 06:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more